SHED vs Ro for GLP-1 Weight Loss: Which Actually Fits You in 2026?

By the Weight Loss Provider Guide Editorial Team · Last verified: April 21, 2026 · Updated quarterly.

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. Some links on this page pay us a commission if you sign up. We only recommend providers we’d send a friend to, and we’ll tell you plainly when the other one fits you better. Affiliate disclosure.

The short answer (if you’re skimming)

SHED vs Ro comes down to one real trade-off: format flexibility with a provider-backed 10% weight-loss program policy, or FDA-approved brand-name medication with help using your insurance.

Pick SHED if you want:

  • Options beyond a weekly injection — sublingual drops, dissolvable lozenges, oral liposomal tablets, or compounded injections
  • SHED's published program policy that offers a refund of subscription fees if you don't lose at least 10% of your body weight in 9 months (full terms apply)

Pick Ro if you want:

  • FDA-approved brand-name medication (Wegovy, Zepbound, Foundayo) at cash prices matched to LillyDirect®, NovoCare®, and TrumpRx
  • Commercial insurance you want help using — Ro has a dedicated insurance concierge that handles prior-authorization paperwork

Neither is universally better. The right answer depends on which operating model fits your situation, and we’ll show you the math so you can decide in under three minutes.

SHED vs Ro: Which GLP-1 Provider Fits You Best? A quick side-by-side look at the biggest differences. SHED: best for cash-pay shoppers who want more format flexibility, compounded GLP-1 options and multiple format choices plus brand-name pathways, injections/sublingual drops/dissolvable lozenges/oral liposomal tablets plus brand-name options, best fit for cash-pay users with HSA/FSA accepted, no-needle compounded options or broader format choice. Ro: best for people who want FDA-approved brand-name GLP-1s and insurance support, FDA-approved brand-name GLP-1 options, brand-name oral and injectable GLP-1 options, strong fit for users who want insurance help and prior-authorization support, FDA-approved medication and help checking coverage. Quick takeaway: Choose SHED if you want cash-pay flexibility and more format options. Choose Ro if you want FDA-approved brand-name GLP-1s and help with insurance.

SHED vs Ro — side-by-side at a glance.Take the 60-sec matcher →

How We Compared SHED vs Ro

Answer capsule: We compared SHED and Ro using each platform’s public pricing pages, product pages, Help Center content, and published Terms, plus FDA guidance on compounded GLP-1s and the CMS Medicare GLP-1 Bridge program. Last reviewed April 21, 2026. We flag where provider public pages disagree with each other rather than pretending the picture is cleaner than it is.

We checked:

  • Pricing: Ro's weight-loss pricing page, Wegovy pill page, Wegovy cost page, Zepbound KwikPen page, and Foundayo page. SHED's category page, brand-name product pages for Wegovy, Zepbound, and Foundayo, plus their compounded injection, liquid drops, lozenges, and oral liposomal tablet pages.
  • Commitment and cancellation: SHED's Help Center subscription pages for the 2-month minimum and 72-hour cancellation window. Ro's pricing and terms pages for the 48-hour renewal window.
  • Insurance workflows: Ro's free GLP-1 Insurance Coverage Checker, Ro's published insurance concierge description, and SHED's brand-name product page language on 'insurance or cash-pay options.'
  • Medication menus: Live SHED product pages (Foundayo, Wegovy, Zepbound added to the FDA-approved lineup) and Ro's current weight-loss product lineup.
  • Service signals: Trustpilot ratings and review counts for both platforms. BBB profiles for both, including rating, accreditation status, and complaint counts.
  • Regulatory context: FDA guidance on compounded GLP-1s, the 2024–2025 end of the semaglutide/tirzepatide shortage, Foundayo (orforglipron) FDA approval on April 1, 2026, and CMS documentation on the Medicare GLP-1 Bridge and BALANCE Model.

We distinguish three kinds of claims: verified commercial facts (pricing, terms, availability — sourced to each provider’s current pages), regulatory facts (sourced to FDA/CMS primary materials), and editorial judgments (who each one fits best — framed as our opinion based on the verified facts above, not medical advice). Where SHED’s own pages disagree on pricing or fees across products, we call that out instead of hiding it.

SHED vs Ro at a Glance

Answer capsule: SHED is a telehealth platform built around medication-format flexibility (injection, drops, lozenges, oral tablets, plus FDA-approved Wegovy, Zepbound, and Foundayo) with a published 10% body-weight program policy that refunds subscription fees if you don’t hit the milestone in 9 months. Ro is a membership-based platform focused on FDA-approved brand-name GLP-1s with cash prices matched to LillyDirect®, NovoCare®, and TrumpRx, plus a dedicated insurance concierge service.
SHED vs Ro — 30-second comparison. Verified April 21, 2026.
CategorySHED (tryshed.com)Ro (ro.co/weight-loss)
Best forCash-pay, no-needle, or compounded-flexibility shoppersInsurance-covered or FDA-approved brand-name shoppers
Medication focusCompounded injections, drops, lozenges, oral tablets + Foundayo, Wegovy, Zepbound (brand pathway)FDA-approved Wegovy pill/pen, Zepbound pen/KwikPen, Foundayo
Compounded optionsBroad — injections, drops, lozenges, oral liposomal tabletsNot a primary focus in 2026
FDA-approved brandWegovy, Zepbound, Foundayo via SHED brand-name pathway (separate fees apply)Foundayo, Wegovy pill/pen, Zepbound pen/KwikPen — manufacturer-matched cash pricing
Insurance billingCompounded: cash-pay only, HSA/FSA accepted. Brand-name pages indicate "insurance or cash-pay options"No direct billing, but insurance concierge submits prior-auth paperwork to your plan
Prior-auth helpNot publicly described as a dedicated serviceYes — dedicated team handles the paperwork
Free insurance checkNot publicly offeredYes — free GLP-1 Insurance Coverage Checker ($50 new-account credit)
10% program policyYes — refund of subscription/service fees if eligible members complete 9 months and don't achieve 10% body-weight loss (terms apply)No equivalent program policy
Cancellation window72 hours before next billing, after a 2-month minimum48 hours before renewal; monthly plan is month-to-month
Visit modelAsync intake; video may be required in some statesAsync online visit; metabolic lab may be requested
State availabilityAll 50 states (not Puerto Rico)All 50 states + Washington, D.C.
Shipping (compounded)1–3 business days to process + 2–6 to shipN/A — no compounded path
Shipping (brand-name)10–15 business daysUnder 1 week (cash-pay); ~2 weeks with insurance/prior-auth
Trustpilot (April 2026)4.6 / 5 from 883 reviews3.7 / 5 from 3,277 reviews
BBB (April 2026)B rating, not accredited, 237 complaints / 3 yrs, pattern-of-complaints alertB rating, BBB accredited, 528 complaints filed

Note on service signals: Trustpilot and BBB numbers reflect customer service experience, not medical efficacy or safety. Platforms with broader product lines and more total customers can show lower average scores simply because more people leave reviews.

What It Actually Costs: SHED vs Ro Pricing Architecture

Answer capsule: Ro’s $39 first-month price is the Ro Body membership fee — medication is billed separately at LillyDirect®, NovoCare®, and TrumpRx cash-pay rates, or through insurance. SHED’s compounded path has one visible price covering medication plus basic care; SHED’s brand-name pages add a separate $99–$125 provider fee on top of medication, and those fees vary across products. Both platforms have headline prices that hide the real monthly cost.

How Ro’s Pricing Actually Works

Ro charges two things, billed separately:

1. Ro Body membership

  • $39 for the first month
  • $149/month on monthly billing after month one
  • As low as $74/month when you prepay for the annual plan upfront
  • Covers Ro-affiliated provider access, care team, insurance concierge, and platform features. Does not include medication.
  • You’re only charged the membership fee if you’re eligible for treatment after the online visit.

2. The medication (priced separately)

Cash-pay path — Ro’s published pricing (verified April 2026):

Ro medication cash-pay pricing. Membership ($39 first month, $149/mo ongoing) billed separately. Verified April 21, 2026.
MedicationFirst monthOngoing (by dose)
Wegovy® pill (oral semaglutide)$149$199–$299
Foundayo® (orforglipron, oral FDA-approved)$149$199–$299
Wegovy® pen (semaglutide injection)$199$199–$349
Zepbound® KwikPen (tirzepatide, cash-pay only)$299$399–$449
Prepay & Save on Ro unlocks up to $100/month off the Wegovy pen and $50/month off the Wegovy pill when you commit annually. Insurance path: If your commercial plan covers the GLP-1, your copay can drop to as low as $25/month when combined with the manufacturer Wegovy Savings Offer or Zepbound Savings Card.

What that means in practice: First month on Ro cash-pay Wegovy pill = $39 + $149 = $188 total. First month on Ro Zepbound KwikPen = $39 + $299 = $338 total. First month on Ro with commercial insurance covering Wegovy could be $39 + $25 copay = $64 total.

How SHED’s Pricing Actually Works

SHED splits into two pricing lanes, and the brand-name lane has some inconsistency across products worth knowing before you commit.

1. Compounded lane (no separate membership)

Visible price covers medication plus basic clinical care and unlimited follow-up appointments. Based on current SHED product pages (April 2026):

  • Compounded semaglutide injection: starts at $199/month
  • Compounded tirzepatide injection: starts at approximately $299/month
  • GLP-1 lozenges (dissolvable, daily): starts at $199/month
  • GLP-1 liquid drops (sublingual, daily): starts at approximately $229/month
  • Oral semaglutide liposomal tablets: verify price at checkout

Prices can rise at higher titrated doses. HSA/FSA cards are accepted.

2. Brand-name lane — provider fees, with some inconsistency across products

Editorial note: SHED’s brand-name product pages currently display inconsistent fee structures across different products. We’re reporting what the public pages show, not inventing a clean number. Verify in the checkout flow before you pay — the intake is free to complete.
SHED brand-name pathway pricing. Additional SHED fee stacks on top of medication. Verified April 21, 2026.
Brand-name pathMedication starting atAdditional SHED fee
Wegovy® via SHED$149/month +$125/month Shed Membership (per current Wegovy product page)
Foundayo® via SHED$149/month +$125/month membership/provider fee (per current Foundayo product page)
Zepbound® via SHED$349/month cash-pay path +$99 Shed membership/provider fee (per current Zepbound product page; $125 framing also appears in places)

Side-by-Side: Typical First-Month Cost

Typical first-month all-in cost comparison by scenario. Verified April 21, 2026.
ScenarioSHED first monthRo first monthWinner
Compounded semaglutide injection (cash-pay)~$199Not offeredSHED
Lozenges or sublingual drops (no needle, cash-pay)$199–$229Not offeredSHED
Wegovy® pen with commercial insurance covering medicationSHED fee + plan copay; SHED does not submit prior auth$39 + potentially $25 copay = ~$64 totalRo
Wegovy® pill cash-pay (low dose)~$149 + $125 fee = ~$274$39 + $149 = $188Ro
Zepbound® KwikPen cash-pay$349 + $99 fee = ~$448 (per current SHED page)$39 + $299 = $338Ro
Foundayo® cash-pay (low dose)~$149 + $125 fee = ~$274$39 + $149 = $188Ro

The honest pricing takeaway

  • Ro is the clearer winner for FDA-approved brand-name medication at cash prices. The membership is the only extra fee, and Ro’s medication prices are matched to manufacturer pricing (LillyDirect®, NovoCare®, TrumpRx). Insurance can drop the real monthly cost dramatically.
  • SHED is the clearer winner for compounded medication and no-needle formats. The compounded lane has no separate membership layer, and SHED’s 10% program policy offers a refund path for subscription fees that Ro doesn’t match.
  • Where SHED loses to Ro on the math: SHED’s brand-name pathway stacks a $99–$125 provider fee on top of brand-name medication that Ro already prices at manufacturer-matched rates. If you specifically want brand-name Wegovy, Zepbound, or Foundayo, Ro is almost always cheaper month one and ongoing.

Medications and Formats: What Each Platform Carries

Answer capsule: SHED’s lineup includes compounded semaglutide and tirzepatide in four formats (injection, sublingual drops, dissolvable lozenges, oral liposomal tablets), plus FDA-approved Wegovy, Zepbound, and Foundayo through a separate brand-name pathway. Ro focuses on FDA-approved brand-name medication: Wegovy pill, Wegovy pen, Zepbound pen and KwikPen, and Foundayo, at manufacturer-matched cash prices or through insurance with prior-auth support.

SHED’s current menu (April 2026)

  • CCompounded GLP-1 injections — semaglutide and tirzepatide
  • CGLP-1 liquid drops — sublingual, once-daily
  • CGLP-1 lozenges — dissolvable, once-daily
  • COral semaglutide liposomal tablets — once-daily
  • CMicrodose GLP-1 — lower-dose program
  • FDA-approved Foundayo® (orforglipron) — brand-name pathway
  • FDA-approved Wegovy® pill and pen — brand-name pathway
  • FDA-approved Zepbound® — brand-name pathway
  • ~Non-GLP-1 options: Metformin+Naltrexone+Topiramate, MIC+B12, Naltrexone+Bupropion

C = compounded, ✓ = FDA-approved

Ro’s current menu (April 2026)

  • FDA-approved Wegovy® pill (oral semaglutide) — cash or insurance
  • FDA-approved Wegovy® pen (subcutaneous injection) — cash or insurance
  • FDA-approved Zepbound® pen (tirzepatide) — cash or insurance
  • FDA-approved Zepbound® KwikPen (tirzepatide) — cash-pay only, matches LillyDirect®
  • FDA-approved Foundayo® (orforglipron) — cash or insurance
  • Free GLP-1 Insurance Coverage Checker — standalone tool; $50 credit for new Ro accounts
Required regulatory disclosure: Compounded medications are prepared by a licensed pharmacy based on a provider’s prescription. They are not reviewed or approved by the FDA as finished products. Compounded oral formats specifically (drops, lozenges, tablets) have not been studied through the same clinical trials as FDA-approved injectable GLP-1s — the FDA has expressed safety concerns about certain compounded GLP-1 products, including some adverse events tied to dosing errors. If a compounded path is the right fit for you, it should be based on a conversation with a licensed provider about your specific situation. FDA source

Compounded vs FDA-Approved: What Actually Matters Before You Click

Answer capsule: FDA-approved GLP-1s have been reviewed by the FDA for safety, efficacy, and manufacturing consistency. Compounded GLP-1s are prepared by 503A or 503B pharmacies under individual prescriptions and are not FDA-reviewed as finished products. SHED carries both; Ro focuses on the FDA-approved lane. The FDA has enforced against compounders marketing non-approved GLP-1s as equivalent to brand-name drugs.

FDA-approved means:

  • The FDA has reviewed the medication for safety, efficacy, and manufacturing consistency
  • The label tells you what dose, what indication, and what the clinical trials showed
  • Wegovy (semaglutide 2.4mg) produced average ~15% weight loss over 68 weeks in trials
  • Zepbound (tirzepatide) produced average ~20% weight loss in similar trial populations

Individual results vary significantly and depend on dose, adherence, and lifestyle.

Compounded means:

  • A licensed pharmacy prepared the medication based on your prescription
  • Typically for a documented patient-specific medical need (different dose, route, or allergy)
  • 503A (patient-specific) or 503B (outsourcing facility) pharmacies under USP standards
  • SHED states it uses pharmacies meeting USP <795> and USP <797> compounding standards and holds LegitScript approval

The regulatory picture in 2026:

FDA declared the semaglutide and tirzepatide shortages over in 2024–early 2025, and the grace periods for compounding essentially-identical copies ended in May 2025. Compounded GLP-1s can still legally be prepared in certain situations — non-identical formulations, specific documented medical needs. Cost is not a valid reason under FDA guidance. Adding vitamin B12 is not enough by itself.

What this means for your decision: If clinical certainty and manufacturer-backed trial data matter most, choose an FDA-approved path — Ro leads here. If price, format variety, or an oral route that isn’t a pill matters more — and you’ve discussed compounded appropriateness with a provider — SHED is built for that.

Needle-Free Options: SHED’s Compounded Variety vs Ro’s FDA-Approved Pills

Answer capsule: SHED’s current product menu lists three compounded non-injection formats (sublingual drops, dissolvable lozenges, oral liposomal tablets) plus FDA-approved Wegovy pill and Foundayo via its brand-name pathway. Ro offers two non-injection formats: FDA-approved Wegovy pill and Foundayo, both at manufacturer-matched cash prices. SHED offers wider format variety; Ro offers narrower but FDA-approved options at lower prices on those specific products.

SHED’s no-needle options

  • CSublingual drops (compounded) — placed under the tongue daily
  • CDissolvable lozenges (compounded) — dissolved under the tongue daily
  • COral liposomal tablets (compounded) — once-daily oral tablet
  • Wegovy® pill (FDA-approved) — via brand-name pathway ($149 + $125 SHED fee)
  • Foundayo® (FDA-approved oral) — via brand-name pathway ($149 + $125 SHED fee)

Ro’s no-needle options

  • Wegovy® pill — $149 first month, $199–$299 ongoing cash-pay; potentially $25/month with insurance + savings offer
  • Foundayo® — $149 first month, $199–$299 ongoing cash-pay; insurance-eligible
Honest routing: If you want an FDA-approved oral pill with clinical trial data, Wegovy pill or Foundayo are the options — and Ro’s cash pricing on these is tighter (no second fee layer). If you want a non-injection route that isn’t an FDA-approved pill — sublingual drops, dissolvable lozenges, or oral liposomal tablets — SHED’s menu is broader. Those formats are compounded and not FDA-approved as finished products, and clinical trial evidence for oral/sublingual semaglutide absorption pathways is limited compared to injectable GLP-1s.

Insurance and Prior Authorization: Only One of Them Fights Your Paperwork

Answer capsule: Ro has a dedicated insurance concierge that submits prior-authorization paperwork to your commercial insurance and a free GLP-1 Insurance Coverage Checker (a separate standalone tool with a $50 credit for new accounts). SHED’s compounded lane is cash-pay only with HSA/FSA accepted. SHED’s brand-name product pages indicate “insurance or cash-pay options,” but SHED does not publicly describe a dedicated prior-authorization workflow comparable to Ro’s concierge.

What Ro’s Insurance Workflow Actually Does

1. Free GLP-1 Insurance Coverage Checker

A standalone tool on Ro’s site that tells you whether your plan covers Wegovy, Zepbound, Foundayo, or other brand-name GLP-1s — before you sign up for anything. Ro offers a $50 credit for new accounts that run the check.

2. Insurance concierge (for Ro Body members)

  • Submits prior-authorization paperwork to your commercial insurance
  • Coordinates with manufacturer savings programs — Wegovy Savings Offer and Zepbound Savings Card — lowering copays to as little as $25/month on covered plans
  • Handles appeals when plans deny coverage initially

Typical prior-authorization timeline: 1–3 weeks from request to approval or denial.

Medicare and Medicaid in 2026: Medicare generally does not cover GLP-1s for weight loss, with one important exception — the CMS Medicare GLP-1 Bridge program starts July 1, 2026, providing eligible Medicare Part D beneficiaries access to Foundayo, Wegovy (pen and tablets), and Zepbound KwikPen for weight management. The CMS BALANCE Model is launching as early as May 2026 in participating Medicaid states. Coverage depends on your state and your plan. All covered medications are available through Ro. CMS source

What SHED Does on Insurance

Compounded lane: cash-pay only. HSA and FSA cards are accepted as payment methods, and SHED provides receipts for reimbursement. Brand-name lane: SHED’s product pages for Wegovy and Zepbound currently display language about “insurance or cash-pay options,” but SHED does not publicly describe a dedicated insurance concierge or prior-authorization workflow on the level of Ro’s. If you’re planning to use insurance to cover brand-name medication, you’ll likely do more of the paperwork yourself on SHED than on Ro.

Honest routing by insurance situation:

  • Your commercial plan might cover GLP-1sRo. Run the free Insurance Coverage Checker first. It costs nothing.
  • Your plan clearly excludes weight-loss GLP-1 coverage → Pick based on format. Cash-pay compounded or no-needle → SHED. Cash-pay brand-name → Ro.
  • You’re on Medicare or Medicaid → Check the Medicare GLP-1 Bridge (starts July 1, 2026) and BALANCE Model (rolling out May 2026 in participating states).
Check your insurance coverage for free on Ro (takes 2 minutes) →

Cancellation, Commitment, and the Fine Print That Costs Real Money

Answer capsule: SHED requires a 2-month minimum commitment on subscription programs and requires you to cancel at least 72 hours before your next billing date through the patient portal chat or email. Ro’s monthly plan is month-to-month and requires cancellation at least 48 hours before renewal through account settings. Ro’s cancellation path is materially easier; SHED’s tougher commitment is paired with its 10% body-weight program policy (terms apply).

SHED cancellation rules

  • 2-month minimum on compounded and brand-name subscription programs
  • 72-hour cancellation window — cancel at least 72 hours before next billing date
  • How to cancel: through the secure patient portal chat or by email. No live phone cancellation.
  • Medication already shipped is non-refundable.

Ro cancellation rules

  • No minimum commitment on the monthly plan — month-to-month
  • 48-hour cancellation window — cancel at least 48 hours before renewal
  • Annual prepay plan is annual — refund policies follow the plan terms.
  • How to cancel: through your Ro account settings.
  • Medication already shipped is non-refundable.

SHED’s 10% Program Policy (what it actually says)

  • Eligible new members who complete SHED's program for the full 9 months, comply with required check-ins, and don't achieve at least 10% body-weight loss may request a refund or program credit.
  • The refund is limited to subscription or eligible service fees actually paid during those 9 months, minus any discounts applied.
  • Excluded from the refund: lab fees, shipping, coaching upgrades, supplements, and other add-ons.
  • Full terms, eligibility requirements, and exclusions are on SHED's Terms page.
This is a provider program policy with specific terms and exclusions. It is not a guarantee of weight loss, and outcomes on any GLP-1 depend on medication, dose, adherence, and lifestyle.

The one real trade-off on this page

SHED is not the easier platform to exit. If you want to try a GLP-1 program for 30 days and bail without friction, Ro’s month-to-month model is structurally simpler. Here’s the other side: SHED’s 2-month minimum is part of what makes the 10% program policy possible — it’s an outcome-linked policy that wouldn’t work if users could cycle in and out. Ro doesn’t offer a comparable outcome-linked policy, so it doesn’t need the commitment. If cancellation friction is a dealbreaker for you, don’t sign up for SHED — use Ro’s month-to-month plan.

How Fast Can You Actually Start and Get Medication?

Answer capsule: SHED’s published timing for compounded medication is 1–3 business days to process plus 2–6 business days to ship, for roughly 3–9 business days from approval to delivery. Brand-name medication through SHED takes 10–15 business days. Ro’s published expectation is your first dose in about two weeks if using insurance or less than a week if paying cash. Speed depends more on your payment path than on the platform.

SHED timing

  • Intake: async questionnaire, or video visit depending on state law
  • Approval: provider reviews asynchronously in async states
  • Compounded medication: 1–3 business days to process, 2–6 business days to ship after processing
  • Brand-name medication (Wegovy, Zepbound, Foundayo): 10–15 business days
  • State availability: all 50 states (Puerto Rico not included)

Ro timing

  • Online visit: async questionnaire reviewed by a Ro-affiliated provider
  • Metabolic lab: provider may request before prescribing
  • Published expectation: "Get ready for your first dose in two weeks if using insurance, or less than a week if paying cash"
  • Prior-authorization (insurance path): typically 1–3 weeks
  • State availability: all 50 states + Washington, D.C.
For cash-pay compounded semaglutide or tirzepatide, SHED is usually the fastest path. For cash-pay brand-name medication, both platforms deliver in the sub-two-week range. For insurance-covered brand-name through Ro, the first fill necessarily takes longer because of prior-authorization paperwork — but once you’re approved, refills move at normal pharmacy speed.

What Real Customers Say

Answer capsule: SHED currently holds a 4.6/5 rating on Trustpilot from 883 reviews and a B rating on BBB (not accredited), with 237 complaints filed in three years and a pattern-of-complaints alert. Ro currently holds a 3.7/5 rating on Trustpilot from 3,277 reviews and a B rating on BBB (accredited), with 528 complaints filed. These numbers reflect service and billing experience, not medical outcomes.
4.6 / 5883 reviews

SHED customer experience

“I spoke with Mike and he was very informative and answered any questions I had.”

Typical positives: thorough customer service interactions, care team responsiveness.

Typical negatives: billing confusion — the 28-day billing cycle vs. monthly expectation, the 2-month minimum catching users by surprise.

BBB (April 2026): B rating, not accredited, pattern-of-complaints alert, 237 complaints / 3 years. Responds to 100% of negative Trustpilot reviews.

3.7 / 53,277 reviews

Ro customer experience

“Lots of communication and quick responses.”

Typical positives: the insurance concierge successfully getting commercial plans to cover brand-name medication.

Typical negatives: the $149/month membership feels like a lot on top of medication cost for cash-pay users who don’t use the insurance benefit.

BBB (April 2026): B rating, BBB accredited, 528 complaints filed. Responds to 93% of negative Trustpilot reviews.

Disclosure on testimonials: Per Ro’s pricing page, Ro members were paid for some of the testimonials published on Ro’s own site. SHED’s member stories are presented as self-reported with a “results may vary” disclosure. The quotes above are service-quality quotes from Trustpilot, not outcome claims. Individual results vary with any GLP-1 program.

Who Each One Is Actually Best For (8 Specific Situations)

Answer capsule: The honest answer to “SHED vs Ro” depends on your situation. SHED wins for cash-pay compounded shoppers, no-needle compounded formats, and the 10% program policy. Ro wins for insurance-covered brand-name, cash-pay brand-name, and month-to-month cancellation flexibility.
SHED vs Ro verdict by situation. Verified April 21, 2026.
Your situationWinner
You have commercial insurance that might cover Wegovy or ZepboundRo
You're cash-pay and want FDA-approved Wegovy or ZepboundRo
You're needle-averse and want a compounded oral format (drops, lozenges, liposomal tablets)SHED
You want an FDA-approved oral pill (Wegovy pill or Foundayo)Ro
You want a provider-backed program policy tied to weight-loss outcomesSHED
You want the lowest cash-pay cost on compounded semaglutideSHED
You want the ability to cancel anytime with minimal frictionRo
You're new to GLP-1s and want structured coaching includedSlight edge SHED
Should You Choose SHED or Ro? Use this quick decision guide to find your best-fit path. Start: What matters most to you? → I want FDA-approved brand-name medication → Best fit: Ro. → I want help checking insurance coverage or prior authorization → Best fit: Ro. → I want more delivery formats, including compounded no-needle options → Best fit: SHED. → I want cash-pay flexibility and I'm open to compounded options → Best fit: SHED. → I'm not sure which path matches my situation → Take a GLP-1 matching quiz. Quick fit summary: SHED good for cash-pay users, more format options, compounded no-needle choices. Ro good for FDA-approved brand-name, insurance support, brand-focused path.

Still unsure? Use the flowchart to find your lane — or take the full 60-second matcher.Take the quiz →

Final Verdict: SHED vs Ro

Answer capsule: Choose SHED for no-needle variety, cash-pay compounded flexibility, or SHED’s 10% program policy (terms apply). Choose Ro for FDA-approved brand-name medication, insurance-concierge support, or the easier month-to-month cancellation. Both platforms are legitimate; the right answer depends on which operating model fits your priorities.

Choose SHED if:

You want format flexibility, a real path to compounded oral GLP-1s, and SHED’s program policy that refunds subscription fees if you don’t hit the 10% milestone over 9 months — and you’re willing to commit to a 2-month minimum and a 72-hour cancellation window.

Choose Ro if:

You want FDA-approved Wegovy, Zepbound, or Foundayo at manufacturer-matched cash pricing, help using your commercial insurance through a dedicated concierge, and the ability to cancel month-to-month with just 48 hours’ notice.

Both have real customers, real reviewers, and real complaints. Neither is perfect. Both are better than guessing on your own in a space that changes monthly.

The wrong move is to pick based on which brand ran the ad you remember. The right move is to pick based on which operating model actually fits you.

Ready to Start with SHED?

SHED is the right next step if you want:

  • Compounded semaglutide or tirzepatide injections starting at $199–$299/month with no separate membership
  • No-needle formats: sublingual drops, dissolvable lozenges, or oral liposomal tablets
  • FDA-approved Wegovy, Zepbound, or Foundayo through SHED's brand-name pathway
  • SHED's published 10% program policy backed by a 9-month protocol (terms apply)
  • Cash-pay simplicity with HSA/FSA accepted
See if you qualify and check current SHED pricing in your state →

No payment required to complete the eligibility questionnaire. You’re not charged for medication until after a provider reviews your intake and prescribes.

Ready to Start with Ro?

Ro is the right next step if you want:

  • FDA-approved brand-name GLP-1s: Wegovy pill, Wegovy pen, Zepbound pen, Zepbound KwikPen, Foundayo
  • Free GLP-1 Insurance Coverage Checker — find out if your plan covers the medication before you pay anything ($50 credit available for new accounts)
  • An insurance concierge that submits prior-authorization paperwork to your insurance
  • Cash-pay prices matched to LillyDirect®, NovoCare®, and TrumpRx
  • Month-to-month membership: $39 first month, $149/month ongoing, or as low as $74/month with annual prepay
Check your eligibility and see current Ro pricing →

You’re charged the Ro Body membership fee only if you’re eligible for treatment. The free Insurance Coverage Checker is a separate tool — no Ro Body sign-up required to use it.

Still not sure which GLP-1 program is right for you?

Answer five questions about your situation — insurance status, format preference, commitment tolerance, budget, and dosing plan — and we’ll route you to the provider we’d recommend for your specific answers.

Take the free 60-second GLP-1 matcher

SHED vs Ro Frequently Asked Questions

This article was produced by the Weight Loss Provider Guide Editorial Team. Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We accept affiliate commissions from some providers listed. Editorial rankings and recommendations are based on verified facts and user fit, not payout. Read our editorial standards.

Last verified: April 21, 2026. Next scheduled re-verification: July 2026.

Not medical advice. GLP-1 medications require a prescription and should be used only under the guidance of a licensed healthcare professional. Compounded medications are not FDA-approved as finished products and should be considered in consultation with your provider. Individual results vary. Clinical trial results referenced are from FDA-approved medications under controlled study conditions and do not predict individual outcomes on any specific platform.